CORRESP Filing
HCW Biologics Inc.
Date: May 13, 2025 · CIK: 0001828673 · Accession: 0000950170-25-070016
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287136
Letter
May 13, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HCWB Biologics Inc. Registration Statement on Form S-1 File No. 333-287136 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC (“Maxim”), as placement agent, hereby concurs in the request by HCW Biologics Inc. that the effective date of the above-referenced Registration Statement be accelerated to 5:00 PM, Eastern Time, on Tuesday, May 13, 2025, or as soon thereafter as may be practicable. Maxim affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
May 13, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HCWB Biologics Inc. Registration Statement on Form S-1 File No. 333-287136 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC (“Maxim”), as placement agent, hereby concurs in the request by HCW Biologics Inc. that the effective date of the above-referenced Registration Statement be accelerated to 5:00 PM, Eastern Time, on Tuesday, May 13, 2025, or as soon thereafter as may be practicable. Maxim affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
By:
_/s/ Ritesh Veera ________________
Name: Ritesh Veera Title: Co-Head of Investment Banking
{01524529.DOCX.2}